Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jaka Biotech CoBJSE:920165 20 Net Margin % is 23.98% as of Jun. 2026, which is 2% below its 10-year median of 24.36. GuruFocus rates BJSE:920165 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,960 Consumer Packaged Goods companies, Jaka Biotech Co ranks better than 96.43% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Jaka Biotech Co's Net Income for the
three
months ended in Jun. 2026 was ¥18.3 Mil. Jaka Biotech Co's Revenue for the
three
months ended in Jun. 2026 was ¥76.2 Mil. Therefore, Jaka Biotech Co's net margin for the quarter that ended in Jun. 2026 was 23.98%.
The historical rank and industry rank for Jaka Biotech Co's Net Margin % or its related term are showing as below:
BJSE:920165'
s Net Margin % Range Over the Past 10 Years
Min: 21.85 Med: 24.36 Max: 29.85
Current: 25.65
BJSE:920165's Net Margin % is ranked better than 96.43% of 1960
companies
in the Consumer Packaged Goods industry
Industry Median: 3.525
vs BJSE:920165: 25.65
Jaka Biotech Co (BJSE:920165) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Jaka Biotech Co Net Margin % Related Terms
Jaka Biotech Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Jaka Biotech Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920165 vs PG, CL, EL: Net Margin % Comparison
For the Household & Personal Products subindustry, Jaka Biotech Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jaka Biotech Co Net Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Jaka Biotech Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Jaka Biotech Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaka Biotech Co (BJSE:920165) has a Net Margin % of 23.98% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Jaka Biotech Co and its competitors. This is near median its historical median of 24.36. Over the past decade, Jaka Biotech Co's Net Margin % has ranged from 21.85 to 29.85. According to the industry distribution chart, Jaka Biotech Co ranks #70 out of 1960 companies in the Consumer Packaged Goods industry, placing it in the top 3.6%.
Is Jaka Biotech Co's Net Margin % too high?
Jaka Biotech Co's current Net Margin % of 23.98% is near median its 10-year median of 24.36. Over the past 10 years, this metric has ranged from a low of 21.85 to a high of 29.85. The Consumer Packaged Goods industry median Net Margin % is 3.53. Jaka Biotech Co's value of 23.98% is 580.3% above this industry median. Based on the distribution chart, Jaka Biotech Co ranks #70 out of 1960 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Jaka Biotech Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Jaka Biotech Co's Net Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Jaka Biotech Co ranks #70 out of 1960 companies for Net Margin %. This places Jaka Biotech Co in the top 4% of its industry — outperforming the majority of peers. The industry median Net Margin % is 3.53. Jaka Biotech Co's value of 23.98% is 580.3% above this benchmark. Historically, Jaka Biotech Co's own Net Margin % has ranged from 21.85 to 29.85 over the past decade. While the company's 10-year median is 24.36 vs. the industry median of 3.53, Jaka Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Consumer Packaged Goods company?
The median Net Margin % among Consumer Packaged Goods companies is 3.53, based on 1,960 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jaka Biotech Co's current Net Margin % of 23.98% is 580.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Jaka Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Net Margin % is 3.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jaka Biotech Co's current Net Margin % is 23.98%, which is near median its own 10-year median of 24.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaka Biotech Co stock overvalued right now?
Jaka Biotech Co (BJSE:920165) has a current Net Margin % of 23.98%. The current Net Margin % is 23.98%, which is near median its 10-year median of 24.36 and 580.3% above the Consumer Packaged Goods industry median of 3.53. Jaka Biotech Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Jaka Biotech Co (BJSE:920165), the current Net Margin % is 23.98% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jaka Biotech Co Ltd is engaged in the research, development, production and sales of cosmetic functional ingredients. Its operations include pharmaceutical manufacturing, testing and inspection services, manufacturing and sales of specialty chemical products, and bio-based materials.
20GF Score
Get the complete analysis for BJSE:920165
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920165 has been successfully added to your 
